Biotech Values

[mouton29]

My view on the prospects for a TRO/PI preventing a possible tL launch are the same as they were for Sanofi preventing a mL launch - close to zero

That may be your bottom line view but you have to admit the situations are different in that Sanofi was seeking an injuntion based on the argument that the FDA approval was an improper abuse of discretion, whereas MNTA's argument is that its IP is being infringed. There has probably never been an TRO/PI granted on the former but they have, if rarely, been granted on the latter.